Preview

User

Not a user? Register with this site Forgot your password?

Journal of oncology: diagnostic radiology and radiotherapy

Advanced search
Fullscreen

For citations:

Baranova O.D., Krylov A.S., Zhulikov Y.A., Artamonova E.V., Markovich A.A., Likhosherstova D.V., Filimonov A.V., Tulin P.E., Dolgushin B.I., Stilidi I.S. Interim Results of a Phase I/II Clinical Study to Assess the Safety And Efficacy of Peptide Receptor Radionuclide Therapy with 177Lu-DOTA-TATE Produced by the N.N. Blokhin National Medical Research Center of Oncology in Patients with Neuroendocrine Neoplasia. Journal of oncology: diagnostic radiology and radiotherapy. 2025;8(4):22-29. (In Russ.) https://doi.org/10.37174/2587-7593-2025-8-4-22-29

Views PDF (Rus): 119

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2587-7593 (Print)
ISSN 2713-167X (Online)

115478, Russia, Moscow, Kashirskoye highway, 23, B-2 zone, 4th floor, office 4117

Processing of personal data
supported by NEICON (Elpub lab)